|
"shan y s"的相關文件
顯示項目 6-30 / 95 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國立成功大學 |
2023 |
The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population-based cohort study
|
Yen, C.-C.;Yang, Yang Y.-H.;Ku, H.-Y.;Hu, Hu H.-M.;Lo, S.-S.;Chang, H.-C.;Chao, Y.;Chen, J.-S.;Wang, H.-P.;Wang, T.-E.;Bai, L.-Y.;Wu, M.-S.;Yen, C.-J.;Chen, L.-T.;Shan, Y.-S. |
| 國立成功大學 |
2023 |
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
|
Su, Y.-Y.;Chiang, N.-J.;Chang, J.S.;Wang, Y.-W.;Shen, B.-N.;Li, Y.-J.;Hwang, D.-Y.;Shan, Y.-S.;Chen, L.-T. |
| 國立成功大學 |
2023 |
Is delayed fixation worthwhile in patients with long bone fracture concomitant with mild traumatic brain injury? A propensity score–matched study
|
Yu, T.-P.;Chen, Y.-T.;Ko, P.-Y.;Wu, C.-H.;Yang, T.-H.;Hung, K.-S.;Wu, P.-T.;Wang, C.-J.;Yen, Yen Y.-T.;Shan, Y.-S. |
| 國立成功大學 |
2023 |
An integrated microfluidic system for automatic detection of cholangiocarcinoma cells from bile
|
Chang, J.-L.;Huang, C.-J.;Tsai, Y.-C.;Chiang, N.-J.;Huang, Y.-S.;Hung, S.-C.;Shan, Y.-S.;Lee, G.-B. |
| 臺大學術典藏 |
2022-08-19T00:20:43Z |
Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
|
Chiang N.-J.; CHIUN HSU; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:34Z |
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
|
Chen M.-H.; Chou W.-C.; Hsiao C.-F.; Jiang S.S.; Tsai H.-J.; Liu Y.-C.; CHIUN HSU; Shan Y.-S.; Hung Y.-P.; Hsich C.-H.; Chiu C.-H.; Liu T.-C.; Cho S.-F.; Liu T.-W.; Chao Y. |
| 臺大學術典藏 |
2022-04-20T08:12:03Z |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; CHUN-JU CHIANG; Li A.F.-Y.; Wang H.-P.; Wang T.-E.; Bai L.-Y.; Wu M.-S.; Chen L.-T.; Liu T.-W.; Yang Y.-H. |
| 臺大學術典藏 |
2022-03-08T03:44:02Z |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; SHIH-HUNG YANG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study
|
Su Y.-Y.; Chiu Y.-F.; Li C.-P.; SHIH-HUNG YANG; Lin J.; Lin S.-J.; Chang P.-Y.; Chiang N.-J.; Shan Y.-S.; Ch��ang H.-J.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-02-14T05:27:14Z |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; HSIU-PO WANG; Wang T.-E.; Bai L.-Y.; Wu M.-S.; Chen L.-T.; Liu T.-W.; Yang Y.-H. |
| 臺大學術典藏 |
2022-01-25T07:24:16Z |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu H.-M.; Tsai H.-J.; Ku H.-Y.; Lo S.-S.; Shan Y.-S.; Chang H.-C.; Chao Y.; Chen J.-S.; Chen S.-C.; Chiang C.-J.; Li A.F.-Y.; Wang H.-P.; Wang T.-E.; Bai L.-Y.; MING-SHIANG WU; Chen L.-T.; Liu T.-W.; Yang Y.-H. |
| 國立成功大學 |
2022 |
Electromagnetically-driven integrated microfluidic platform using reverse transcription loop-mediated isothermal amplification for detection of severe acute respiratory syndrome coronavirus 2
|
Tsai, Y.-S.;Wang, C.-H.;Tsai, H.-P.;Shan, Y.-S.;Lee, G.-B. |
| 國立成功大學 |
2022 |
An integrated microfluidic platform featuring real-time reverse transcription loop-mediated isothermal amplification for detection of COVID-19
|
Jhou, Y.-R.;Wang, C.-H.;Tsai, H.-P.;Shan, Y.-S.;Lee, G.-B. |
| 國立成功大學 |
2022 |
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
|
Chiang, N.-J.;Tan, K.T.;Bai, L.-Y.;Hsiao, C.-F.;Huang, C.-Y.;Hung, Y.-P.;Huang, C.-J.;Chen, S.-C.;Shan, Y.-S.;Chao, Y.;Huang, Y.-H.;Lee, I.-C.;Lee, P.-C.;Su, Y.-Y.;Chen, S.-J.;Yeh, C.-N.;Chen, L.-T.;Chen, M.-H. |
| 國立成功大學 |
2022 |
Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin
|
Chiu, T.-J.;Yang, S.-H.;Chiu, S.-C.;Hsueh, S.-W.;Chiang, N.-J.;Li, C.-P.;Bai, L.-Y.;Cheng, F.-M.;Chuang, S.-C.;Shan, Y.-S.;Chan, D.-C.;Chen, L.-T.;Yen, C.-J.;Peng, C.-M.;Su, Y.-Y.;Chen, Y.-Y.;Chen, J.-S.;Chou, W.-C. |
| 國立成功大學 |
2022 |
Exendin-4 Attenuates Hepatic Steatosis by Promoting the Autophagy-Lysosomal Pathway
|
Yu, H.-H.;Wang, H.-C.;Hsieh, M.-C.;Lee, M.-C.;Su, B.-C.;Shan, Y.-S. |
| 國立成功大學 |
2022 |
Review of the endocrine organ–like tumor hypothesis of cancer cachexia in pancreatic ductal adenocarcinoma
|
Yu, Yu Y.-C.;Ahmed, Ahmed A.;Lai, H.-C.;Cheng, W.-C.;Yang, J.-C.;Chang, W.-C.;Chen, L.-M.;Shan, Y.-S.;Ma, W.-L. |
| 國立成功大學 |
2022 |
Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer
|
Park, J.M.;Peng, J.-M.;Shen, Y.-S.;Lin, C.-Y.;Hsu, T.-W.;Su, Y.-H.;Chen, H.-A.;Saengboonmee, C.;Chang, J.-S.;Chiu, Chiu C.-F.;Shan, Y.-S. |
| 國立成功大學 |
2022 |
Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway
|
Hung, Y.-H.;Hsu, S.-H.;Hou, Y.-C.;Chu, P.-Y.;Su, Y.-Y.;Shan, Y.-S.;Hung, W.-C.;Chen, L.-T. |
| 國立成功大學 |
2022 |
A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study
|
Bai, L.-Y.;Li, C.-P.;Shan, Y.-S.;Chuang, S.-C.;Chen, J.-S.;Chiang, N.-J.;Chen, Y.-Y.;Tsou, H.-H.;Chuang, M.-H.;Chiu, Chiu C.-F.;Liu, T.-W.;Chen, L.-T. |
| 國立成功大學 |
2022 |
Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia foll
|
Tai, S.-H.;Huang, S.-Y.;Chao, L.-C.;Lin, Y.-W.;Huang, C.-C.;Wu, T.-S.;Shan, Y.-S.;Lee, A.-H.;Lee, E.-J. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-08-12T04:01:23Z |
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma�VTCOG T1211 study
|
Chiang N.-J.; Tsai K.K.; Hsiao C.-F.; YANG SHIH-HUNG; Hsiao H.-H.; Shen W.-C.; Hsu C.; Lin Y.-L.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
顯示項目 6-30 / 95 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
